Post hoc analysis of 838 patients with ASA failure and recent lacunar stroke from the Secondary Prevention of Small Subcortical Strokes Trial ( SPS3 ) cohort randomly allocated to aspirin ( 325 mg/day ) and clopidogrel ( 75 mg/day ) or placebo .